Proteoforms in 2016 Savaryn, Toby et al., Proteomics, Human PBMC, Sample Set 1

PFR Accession Description Modifications Length Confidence
16273 Q93077 Histone H2A type 1-C N-Terminal Acetylation, Deamidation@4, Acetylation@6, Acetylation@10, Monomethylation@105 129
16667 Q93077 Histone H2A type 1-C Monomethylation@105 129
16987 Q93077 Histone H2A type 1-C 103
17281 Q93077 Histone H2A type 1-C N-Terminal Acetylation, Phosphorylation@2, Deamidation@4, Acetylation@6, Acetylation@10 129
18735 Q92686 Neurogranin N-Terminal Acetylation 78
18736 Q92686 Neurogranin 57
18737 Q92686 Neurogranin 78
18738 Q92686 Neurogranin 43
18739 Q92686 Neurogranin N-Terminal Acetylation 77
18740 Q92686 Neurogranin 56
18741 Q92686 Neurogranin 42
18742 Q92686 Neurogranin 55
18744 Q92686 Neurogranin 48
18745 Q92686 Neurogranin 45
18746 Q92686 Neurogranin 51
18780 Q8WWA1-2 Transmembrane protein 40 N-Terminal Acetylation 88
16539 Q8WVX3-1 Uncharacterized protein C4orf3 N-Terminal Acetylation 66
16144 Q8WUW1-1 Protein BRICK1 N-Terminal Acetylation 74
16867 Q8TAD7 Overexpressed in colon carcinoma 1 protein 63
15254 Q8NI22-1 Multiple coagulation factor deficiency protein 2 120